Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
7.74
-1.16 (-13.03%)
At close: Mar 28, 2025, 4:00 PM
7.37
-0.37 (-4.78%)
Pre-market: Mar 31, 2025, 8:49 AM EDT
Aardvark Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$31.50
Upside
+306.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $22 → $26 | Strong Buy | Maintains | $22 → $26 | +235.92% | Mar 27, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $21 | Buy | Initiates | $21 | +171.32% | Mar 10, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $50 | Buy | Initiates | $50 | +545.99% | Mar 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $29 | Buy | Initiates | $29 | +274.68% | Mar 10, 2025 |
| B of A Securities | B of A Securities | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +184.24% | Mar 10, 2025 |